首页 > 最新文献

Medical Decision Making最新文献

英文 中文
Co-designing a Structured Expert Elicitation with Clinicians to Enhance Health Care Decision Making in Exercise Oncology. 与临床医生共同设计结构化专家启发式以增强运动肿瘤学的医疗保健决策。
IF 3.1 3区 医学 Q2 HEALTH CARE SCIENCES & SERVICES Pub Date : 2025-07-01 Epub Date: 2025-04-25 DOI: 10.1177/0272989X251332967
Yufan Wang, Alexandra L McCarthy, Haitham Tuffaha

BackgroundWhile structured expert elicitation (SEE) is gaining traction in health technology assessment in situations in which data are scarce, its application in practice remains limited. Co-designing a practical and fit-for-purpose SEE with experts could enhance its acceptability and feasibility in clinical research.ObjectivesAn SEE was co-designed with clinicians to elicit expert opinions on 3 uncertain quantities of interest (QoIs) for a decision-analytic model in exercise oncology.MethodsA series of co-design meetings was convened to design 6 elicitation stages. Individual elicitation was conducted using the variable interval method (VIM), via videoconferencing. Linear pooling was adopted to generate group estimates. Semi-structured interviews were conducted after the elicitation exercise to gather the experts' first-hand experience of the elicitation process and to identify areas for improvement. Qualitative data were transcribed and content analyzed.ResultsTwelve experts participated in the co-designed SEE. Three beta distributions were derived and estimated from the experts' responses: the relative risk reduction of cardiovascular events of exercise for women who survived early-stage endometrial cancer (Mean: 0.362, SD: 0.15), the probability that a clinician would refer a patient to the exercise program (Mean: 0.457, SD: 0.218), and the probability that a cancer patient would use such a health service upon referral (Mean: 0.446, SD: 0.203). Most of the experts' first-hand experience of the co-designed SEE was positive. The qualitative feedback highlighted critical aspects of the elicitation process that should be designed and executed with caution when targeting clinicians with no prior experience of SEE.ConclusionsThis is the first expert elicitation conducted in exercise oncology. Engaging diverse stakeholders through co-design meetings and incorporating qualitative feedback proved effective and practical in introducing expert elicitation into clinical research.HighlightsRecent SEE guidelines aim to facilitate the conduct of expert elicitation in model-based economic evaluation, but its application in practice remains limited.Engaging experts in the design of SEE could enhance its acceptability and feasibility in clinical research.This is the first co-designed expert elicitation involving clinicians in the field of exercise oncology.This practical approach to conducting SEE could promote a wider adoption to inform health care policy decisions when the evidence is lacking or uncertain.

虽然结构化专家启发(SEE)在数据匮乏的情况下在卫生技术评估中越来越受到关注,但其在实践中的应用仍然有限。与专家共同设计实用、符合目的的SEE,可提高其在临床研究中的可接受性和可行性。目的:与临床医生共同设计SEE,对运动肿瘤学决策分析模型中的3个不确定兴趣量(qoi)征求专家意见。方法召开一系列共同设计会议,设计6个启发阶段。个体启发采用可变间隔法(VIM),通过视频会议进行。采用线性池化方法产生群体估计。在启发过程后进行了半结构化访谈,以收集专家对启发过程的第一手经验,并确定需要改进的领域。对定性资料进行转录和内容分析。结果12位专家参与了共同设计的SEE。从专家的回答中得出并估计了三个beta分布:运动对早期子宫内膜癌存活妇女心血管事件的相对风险降低(平均值:0.362,SD: 0.15),临床医生将患者转介到运动项目的概率(平均值:0.457,SD: 0.218),以及癌症患者在转诊时使用此类健康服务的概率(平均值:0.446,SD: 0.203)。大多数专家对合作设计的SEE的第一手经验都是积极的。定性反馈强调了启发过程的关键方面,当针对没有SEE经验的临床医生时,应该谨慎设计和执行。结论首次在运动肿瘤学领域开展专家启发。事实证明,通过共同设计会议和纳入定性反馈,让不同利益相关者参与进来,在将专家启发引入临床研究方面是有效和实用的。最近的SEE指南旨在促进在基于模型的经济评估中进行专家启发,但其在实践中的应用仍然有限。让专家参与SEE的设计可以提高其在临床研究中的可接受性和可行性。这是第一个涉及运动肿瘤学领域临床医生的共同设计的专家启发。这种实施SEE的实用方法可以促进更广泛的采用,以便在缺乏证据或不确定的情况下为卫生保健政策决策提供信息。
{"title":"Co-designing a Structured Expert Elicitation with Clinicians to Enhance Health Care Decision Making in Exercise Oncology.","authors":"Yufan Wang, Alexandra L McCarthy, Haitham Tuffaha","doi":"10.1177/0272989X251332967","DOIUrl":"10.1177/0272989X251332967","url":null,"abstract":"<p><p>BackgroundWhile structured expert elicitation (SEE) is gaining traction in health technology assessment in situations in which data are scarce, its application in practice remains limited. Co-designing a practical and fit-for-purpose SEE with experts could enhance its acceptability and feasibility in clinical research.ObjectivesAn SEE was co-designed with clinicians to elicit expert opinions on 3 uncertain quantities of interest (QoIs) for a decision-analytic model in exercise oncology.MethodsA series of co-design meetings was convened to design 6 elicitation stages. Individual elicitation was conducted using the variable interval method (VIM), via videoconferencing. Linear pooling was adopted to generate group estimates. Semi-structured interviews were conducted after the elicitation exercise to gather the experts' first-hand experience of the elicitation process and to identify areas for improvement. Qualitative data were transcribed and content analyzed.ResultsTwelve experts participated in the co-designed SEE. Three beta distributions were derived and estimated from the experts' responses: the relative risk reduction of cardiovascular events of exercise for women who survived early-stage endometrial cancer (Mean: 0.362, SD: 0.15), the probability that a clinician would refer a patient to the exercise program (Mean: 0.457, SD: 0.218), and the probability that a cancer patient would use such a health service upon referral (Mean: 0.446, SD: 0.203). Most of the experts' first-hand experience of the co-designed SEE was positive. The qualitative feedback highlighted critical aspects of the elicitation process that should be designed and executed with caution when targeting clinicians with no prior experience of SEE.ConclusionsThis is the first expert elicitation conducted in exercise oncology. Engaging diverse stakeholders through co-design meetings and incorporating qualitative feedback proved effective and practical in introducing expert elicitation into clinical research.HighlightsRecent SEE guidelines aim to facilitate the conduct of expert elicitation in model-based economic evaluation, but its application in practice remains limited.Engaging experts in the design of SEE could enhance its acceptability and feasibility in clinical research.This is the first co-designed expert elicitation involving clinicians in the field of exercise oncology.This practical approach to conducting SEE could promote a wider adoption to inform health care policy decisions when the evidence is lacking or uncertain.</p>","PeriodicalId":49839,"journal":{"name":"Medical Decision Making","volume":" ","pages":"602-613"},"PeriodicalIF":3.1,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12166139/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144019947","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Machine Learning-Based Prediction to Support ICU Admission Decision Making among Very Old Patients with Respiratory Infections: A Proof of Concept on a Nationwide Population-Based Cohort Study. 基于机器学习的预测支持高龄呼吸道感染患者的ICU入院决策:一项基于全国人群的队列研究的概念验证
IF 3.1 3区 医学 Q2 HEALTH CARE SCIENCES & SERVICES Pub Date : 2025-07-01 Epub Date: 2025-05-16 DOI: 10.1177/0272989X251337314
Lionel Tchatat Wangueu, Arthur Kassa-Sombo, Guy Ilango, Christophe Gaborit, Mustapha Si-Tahar, Leslie Grammatico-Guillon, Antoine Guillon

BackgroundIntensive care unit (ICU) hospitalizations of very old patients with acute respiratory infection have risen. The decision-making process for ICU admission is multifaceted, and the prediction of long-term survival outcome is an important component. We hypothesized that data-driven algorithms could build long-term prediction by examining massive real-life data. Our objective was to assess machine learning (ML) algorithms to predict the 1-y survival of very old patients with severe respiratory infections.MethodsA national 2011-2020 study of ICU patients ≥80 y with respiratory infection was carried out, using French hospital discharge databases. Data for the training cohort were collected from 2013 to 2016 to build the models, and the data of patients extracted in 2017 were used for external validation. Our proposed models were developed using random forest, logistic regression (LR), and XGBoost. The optimal model was selected based on its accuracy, sensitivity, specificity, Matthews coefficient correlation (MCC), receiver-operating characteristic curve (AUROC), and decision curve analysis (DCA). The local interpretable model-agnostic explanation (LIME) algorithm was used to analyze the contribution of individual features.ResultsA total of 24,270 very old patients were hospitalized in the ICU for respiratory infection (2013-2017) with a known vital status at 1 y. The 1-y survival rate was 41.3% (median survival: 3 mo [2.7-3.3]). Of the 3 ML models tested, LR exhibited promising performance with an accuracy, sensitivity, specificity, MCC, and AUROC (95% confidence interval) of 0.65, 0.76, 0.60, 0.27, and 0.70 (0.69-0.72), respectively. LR achieved an AUROC of 0.70 (0.68-0.71) in external validation by temporal splitting. LR demonstrated higher net benefits across a range of threshold probability values in DCA. The LIME algorithm identified the 10 most influential features at an individual scale.ConclusionsWe demonstrated that a ML model has the potential to predict long-term outcomes for very old patients with acute respiratory infections. As a proof of concept, we proposed a program that acts as an "explainer" for the ML model. This work represents a step forward in translating ML models into practical, transparent, and reliable clinical tools to support medical decision making.HighlightsThe decision to admit a very old patient to the ICU is one of the most complex challenges faced by intensivists, often relying on subjective judgment.In this study, we evaluated the efficacy of machine learning algorithms in predicting the 1-y survival rate of critically ill very old patients (≥80 y) with severe respiratory infections, using data available prior to the admission decision.Our findings demonstrate that machine learning can effectively predict long-term outcomes in very old patients. We used an innovative approach that aims to support medical decision making about admission in ICU.

背景:高龄急性呼吸道感染患者的重症监护病房(ICU)住院率有所上升。ICU入院的决策过程是多方面的,长期生存结果的预测是一个重要组成部分。我们假设数据驱动的算法可以通过检查大量的现实数据来建立长期预测。我们的目标是评估机器学习(ML)算法,以预测高龄严重呼吸道感染患者的1年生存率。方法采用法国医院出院数据库,对2011-2020年ICU≥80岁呼吸道感染患者进行研究。培训队列数据收集于2013年至2016年建立模型,2017年提取的患者数据用于外部验证。我们提出的模型是使用随机森林、逻辑回归(LR)和XGBoost开发的。根据模型的准确性、敏感性、特异性、马修斯相关系数(MCC)、受者-工作特征曲线(AUROC)和决策曲线分析(DCA)筛选出最优模型。采用局部可解释模型不可知论解释(LIME)算法分析个体特征的贡献。结果2013-2017年ICU共收治1岁生命体征已知的特高龄呼吸道感染患者24270例。1年生存率为41.3%(中位生存期:3个月[2.7-3.3])。在测试的3 ML模型中,LR表现出良好的性能,其准确性、敏感性、特异性、MCC和AUROC(95%置信区间)分别为0.65、0.76、0.60、0.27和0.70(0.69-0.72)。在时间分裂外部验证中,LR的AUROC为0.70(0.68-0.71)。在DCA的阈值概率值范围内,LR显示出更高的净效益。LIME算法在个体尺度上确定了10个最具影响力的特征。结论:我们证明ML模型具有预测高龄急性呼吸道感染患者长期预后的潜力。作为概念验证,我们提出了一个程序,作为ML模型的“解释器”。这项工作代表了将ML模型转化为实用、透明和可靠的临床工具以支持医疗决策的一步。对于重症监护医师来说,接纳高龄患者入住ICU的决定是最复杂的挑战之一,往往依赖于主观判断。在这项研究中,我们评估了机器学习算法在预测严重呼吸道感染的危重极老患者(≥80岁)1年生存率方面的有效性,使用入院决定之前的可用数据。我们的研究结果表明,机器学习可以有效地预测高龄患者的长期预后。我们采用了一种创新的方法,旨在支持ICU住院的医疗决策。
{"title":"Machine Learning-Based Prediction to Support ICU Admission Decision Making among Very Old Patients with Respiratory Infections: A Proof of Concept on a Nationwide Population-Based Cohort Study.","authors":"Lionel Tchatat Wangueu, Arthur Kassa-Sombo, Guy Ilango, Christophe Gaborit, Mustapha Si-Tahar, Leslie Grammatico-Guillon, Antoine Guillon","doi":"10.1177/0272989X251337314","DOIUrl":"10.1177/0272989X251337314","url":null,"abstract":"<p><p>BackgroundIntensive care unit (ICU) hospitalizations of very old patients with acute respiratory infection have risen. The decision-making process for ICU admission is multifaceted, and the prediction of long-term survival outcome is an important component. We hypothesized that data-driven algorithms could build long-term prediction by examining massive real-life data. Our objective was to assess machine learning (ML) algorithms to predict the 1-y survival of very old patients with severe respiratory infections.MethodsA national 2011-2020 study of ICU patients ≥80 y with respiratory infection was carried out, using French hospital discharge databases. Data for the training cohort were collected from 2013 to 2016 to build the models, and the data of patients extracted in 2017 were used for external validation. Our proposed models were developed using random forest, logistic regression (LR), and XGBoost. The optimal model was selected based on its accuracy, sensitivity, specificity, Matthews coefficient correlation (MCC), receiver-operating characteristic curve (AUROC), and decision curve analysis (DCA). The local interpretable model-agnostic explanation (LIME) algorithm was used to analyze the contribution of individual features.ResultsA total of 24,270 very old patients were hospitalized in the ICU for respiratory infection (2013-2017) with a known vital status at 1 y. The 1-y survival rate was 41.3% (median survival: 3 mo [2.7-3.3]). Of the 3 ML models tested, LR exhibited promising performance with an accuracy, sensitivity, specificity, MCC, and AUROC (95% confidence interval) of 0.65, 0.76, 0.60, 0.27, and 0.70 (0.69-0.72), respectively. LR achieved an AUROC of 0.70 (0.68-0.71) in external validation by temporal splitting. LR demonstrated higher net benefits across a range of threshold probability values in DCA. The LIME algorithm identified the 10 most influential features at an individual scale.ConclusionsWe demonstrated that a ML model has the potential to predict long-term outcomes for very old patients with acute respiratory infections. As a proof of concept, we proposed a program that acts as an \"explainer\" for the ML model. This work represents a step forward in translating ML models into practical, transparent, and reliable clinical tools to support medical decision making.HighlightsThe decision to admit a very old patient to the ICU is one of the most complex challenges faced by intensivists, often relying on subjective judgment.In this study, we evaluated the efficacy of machine learning algorithms in predicting the 1-y survival rate of critically ill very old patients (≥80 y) with severe respiratory infections, using data available prior to the admission decision.Our findings demonstrate that machine learning can effectively predict long-term outcomes in very old patients. We used an innovative approach that aims to support medical decision making about admission in ICU.</p>","PeriodicalId":49839,"journal":{"name":"Medical Decision Making","volume":" ","pages":"587-601"},"PeriodicalIF":3.1,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144081638","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Exploring Values Clarification and Health-Literate Design in Patient Decision Aids: A Qualitative Interview Study. 探讨患者决策辅助工具的价值厘清与健康素养设计:一项质性访谈研究。
IF 3.1 3区 医学 Q2 HEALTH CARE SCIENCES & SERVICES Pub Date : 2025-07-01 Epub Date: 2025-05-14 DOI: 10.1177/0272989X251334356
Julie Ayre, Hazel Jenkins, Richie Kumarage, Kirsten J McCaffery, Christopher G Maher, Mark J Hancock

BackgroundThis study explores patient and clinician perceptions of a patient decision aid, focusing on 2 features that are often absent: a health-literate approach (e.g., using plain language, encouraging question asking) and a tool that explicitly shows how treatment options align with patient values. The aim was to gather qualitative feedback from patients and clinicians to better understand how such features might be useful in guiding future decision aid development.MethodsWe present a secondary analysis of data collected during the development of a decision aid for patients considering surgery for sciatica (20 patients with sciatica or low-back pain; 20 clinicians). Patient and clinician feedback on the design was collected via semi-structured interviews with a think-aloud protocol. Transcripts were analyzed using framework analysis.ResultsTheme 1 explored designs that reinforced key messages about personal autonomy, including an interactive values-clarification tool. Theme 2 explored how participants valued encouragement and scaffolding to ask questions. Theme 3 described how patients preferred information they felt was complete, balanced, and understandable.LimitationsFurther experimental and observational research is needed to quantitatively evaluate these decision aid features including evaluation among patients with and without low health literacy.ConclusionsA health-literate approach to decision aid design and embedding an interactive values-clarification tool may be useful strategies for increasing patient capacity to engage in key aspects of shared decision making. These features may support patients in developing an understanding of personal autonomy in the choice at hand and confidence to ask questions.ImplicationsFindings presented here were specific to the clinical context but provide generalizable practical insights for decision aid developers. This study provides insight into potential future areas of research for decision aid design.HighlightsThis qualitative study explored clinician and patient perceptions of health literacy features and an interactive values-clarification task within a decision aid for patients considering surgery for sciatica.The first theme described how patients and clinicians appreciated sections of the decision aid that reinforced the importance of personal choice. Patients and clinicians thought the interactive values-clarification task would help patients reflect on their values and support shared decision-making discussions.The second theme described how patients and clinicians appreciated strategies to encourage patients to ask questions of the surgeon.The third theme described patients' preference for information that they felt was complete, balanced, and understandable.

本研究探讨了患者和临床医生对患者决策辅助工具的看法,重点关注经常缺失的两个特征:健康素养方法(例如,使用简单的语言,鼓励提问)和明确显示治疗方案如何符合患者价值观的工具。目的是收集患者和临床医生的定性反馈,以更好地了解这些特征如何在指导未来决策辅助开发方面有用。方法:我们对考虑手术治疗坐骨神经痛患者决策辅助工具的开发过程中收集的数据进行了二次分析(20例患有坐骨神经痛或腰痛;20临床医生)。患者和临床医生对设计的反馈是通过半结构化访谈收集的。使用框架分析分析转录本。主题1探讨了强化个人自主关键信息的设计,包括一个交互式价值澄清工具。主题2探讨了参与者如何重视鼓励和提问框架。主题3描述了患者如何选择他们认为完整、平衡和可理解的信息。需要进一步的实验和观察研究来定量评估这些辅助决策的特征,包括对健康素养低和不低的患者的评估。结论健康素养的决策辅助设计方法和嵌入交互式价值澄清工具可能是提高患者参与共同决策关键方面能力的有用策略。这些特征可以帮助患者发展对个人自主选择的理解,并有信心提出问题。本文的研究结果是针对临床背景的,但为决策辅助开发人员提供了可推广的实用见解。这项研究为决策辅助设计的潜在未来研究领域提供了见解。本定性研究探讨了临床医生和患者对健康素养特征的看法,并在考虑坐骨神经痛手术的患者决策辅助中进行了交互式价值澄清任务。第一个主题描述了患者和临床医生如何欣赏决策援助中强调个人选择重要性的部分。患者和临床医生认为,互动价值观澄清任务将帮助患者反思他们的价值观,并支持共同决策讨论。第二个主题描述了患者和临床医生如何欣赏鼓励患者向外科医生提问的策略。第三个主题描述了患者对他们认为完整、平衡和可理解的信息的偏好。
{"title":"Exploring Values Clarification and Health-Literate Design in Patient Decision Aids: A Qualitative Interview Study.","authors":"Julie Ayre, Hazel Jenkins, Richie Kumarage, Kirsten J McCaffery, Christopher G Maher, Mark J Hancock","doi":"10.1177/0272989X251334356","DOIUrl":"10.1177/0272989X251334356","url":null,"abstract":"<p><p>BackgroundThis study explores patient and clinician perceptions of a patient decision aid, focusing on 2 features that are often absent: a health-literate approach (e.g., using plain language, encouraging question asking) and a tool that explicitly shows how treatment options align with patient values. The aim was to gather qualitative feedback from patients and clinicians to better understand how such features might be useful in guiding future decision aid development.MethodsWe present a secondary analysis of data collected during the development of a decision aid for patients considering surgery for sciatica (20 patients with sciatica or low-back pain; 20 clinicians). Patient and clinician feedback on the design was collected via semi-structured interviews with a think-aloud protocol. Transcripts were analyzed using framework analysis.ResultsTheme 1 explored designs that reinforced key messages about personal autonomy, including an interactive values-clarification tool. Theme 2 explored how participants valued encouragement and scaffolding to ask questions. Theme 3 described how patients preferred information they felt was complete, balanced, and understandable.LimitationsFurther experimental and observational research is needed to quantitatively evaluate these decision aid features including evaluation among patients with and without low health literacy.ConclusionsA health-literate approach to decision aid design and embedding an interactive values-clarification tool may be useful strategies for increasing patient capacity to engage in key aspects of shared decision making. These features may support patients in developing an understanding of personal autonomy in the choice at hand and confidence to ask questions.ImplicationsFindings presented here were specific to the clinical context but provide generalizable practical insights for decision aid developers. This study provides insight into potential future areas of research for decision aid design.HighlightsThis qualitative study explored clinician and patient perceptions of health literacy features and an interactive values-clarification task within a decision aid for patients considering surgery for sciatica.The first theme described how patients and clinicians appreciated sections of the decision aid that reinforced the importance of personal choice. Patients and clinicians thought the interactive values-clarification task would help patients reflect on their values and support shared decision-making discussions.The second theme described how patients and clinicians appreciated strategies to encourage patients to ask questions of the surgeon.The third theme described patients' preference for information that they felt was complete, balanced, and understandable.</p>","PeriodicalId":49839,"journal":{"name":"Medical Decision Making","volume":" ","pages":"510-521"},"PeriodicalIF":3.1,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12166136/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143992510","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Stress-Testing US Colorectal Cancer Screening Guidelines: Decennial Colonoscopy from Age 45 is Robust to Natural History Uncertainty and Colonoscopy Sensitivity Assumptions. 压力测试美国结直肠癌筛查指南:45岁以后每十年进行一次结肠镜检查,对自然史不确定性和结肠镜敏感性假设是可靠的。
IF 3.1 3区 医学 Q2 HEALTH CARE SCIENCES & SERVICES Pub Date : 2025-07-01 Epub Date: 2025-04-29 DOI: 10.1177/0272989X251334373
Pedro Nascimento de Lima, Christopher Maerzluft, Jonathan Ozik, Nicholson Collier, Carolyn M Rutter

PurposeThe 2023 American College of Physicians (ACP) guidelines for colorectal cancer (CRC) screening are at odds with the United States Preventive Task Force (USPSTF) guidelines, with the former recommending screening starting at age 50 y and the latter at age 45 y. This article "stress tests" CRC colonoscopy screening strategies to investigate their robustness to uncertainties stemming from the natural history of disease and sensitivity of colonoscopy.MethodsThis study uses the CRC-SPIN microsimulation model to project the life-years gained (LYG) under several colonoscopy CRC screening strategies. The model was extended to include birth cohort effects on adenoma risk. We estimated natural history parameters under 2 different assumptions about the youngest age of adenoma initiation. For each, we generated 500 parameter sets to reflect uncertainty in the natural history parameters. We simulated 26 colonoscopy screening strategies and examined 4 different colonoscopy sensitivity assumptions, encompassing the range of sensitivities consistent with prior tandem colonoscopy studies. Across this set of scenarios, we identify efficient screening strategies and report posterior credible intervals for benefits of screening (LYG), burden (number of colonoscopies), and incremental burden-effectiveness ratios.ResultsProjected absolute screening benefits varied widely based on assumptions, but strategies starting at age 45 y were consistently in the efficiency frontier. Strategies in which screening starts at age 50 y with 10-y intervals were never efficient, saving fewer life-years than starting screening at age 45 y and performing colonoscopies every 15 y while requiring more colonoscopies per person.ConclusionsDecennial colonoscopy screening initiation at age 45 y remained a robust recommendation. Colonoscopy screening with a 10-y interval starting at age 50 y did not result in an efficient use of colonoscopies in any of the scenarios evaluated.HighlightsColorectal cancer colonoscopy screening strategies initiated at age 45 y were projected to yield more life-years gained while requiring the least number of colonoscopies across different model assumptions about disease natural history and colonoscopy sensitivity.Colonoscopy screening starting at age 50 y with a 10-y interval consistently underperformed strategies that started at age 45 y.

2023年美国医师学会(ACP)结肠直肠癌(CRC)筛查指南与美国预防工作小组(USPSTF)指南不一致,前者建议从50岁开始筛查,后者建议从45岁开始筛查。本文“压力测试”结直肠癌结肠镜筛查策略,以调查其对疾病自然史和结肠镜敏感性不确定性的稳健性。方法本研究使用CRC- spin微观模拟模型来预测几种结肠镜CRC筛查策略下获得的生命年(LYG)。该模型被扩展到包括出生队列对腺瘤风险的影响。我们在关于腺瘤起始年龄的两种不同假设下估计了自然史参数。对于每一个,我们生成了500个参数集来反映自然历史参数的不确定性。我们模拟了26种结肠镜筛查策略,并检查了4种不同的结肠镜敏感性假设,包括与先前串联结肠镜研究一致的敏感性范围。在这组场景中,我们确定了有效的筛查策略,并报告了筛查收益(LYG)、负担(结肠镜检查次数)和增量负担-有效性比的后验可信区间。结果预测的绝对筛查收益在假设的基础上差异很大,但从45岁开始的策略始终处于效率前沿。50岁开始筛查,间隔10年的策略从来都不是有效的,与45岁开始筛查,每15岁进行一次结肠镜检查相比,节省的生命年更少,而每人需要更多的结肠镜检查。结论:在45岁时开始进行10年一次的结肠镜筛查仍然是强有力的建议。从50岁开始每隔10年进行一次结肠镜检查,在评估的任何情况下都没有有效地使用结肠镜检查。在疾病自然史和结肠镜敏感性的不同模型假设下,预计45岁开始的结直肠癌结肠镜筛查策略可以获得更多的生命年,同时需要最少的结肠镜检查次数。结肠镜筛查从50岁开始,间隔10年,一直低于45岁开始的策略。
{"title":"Stress-Testing US Colorectal Cancer Screening Guidelines: Decennial Colonoscopy from Age 45 is Robust to Natural History Uncertainty and Colonoscopy Sensitivity Assumptions.","authors":"Pedro Nascimento de Lima, Christopher Maerzluft, Jonathan Ozik, Nicholson Collier, Carolyn M Rutter","doi":"10.1177/0272989X251334373","DOIUrl":"10.1177/0272989X251334373","url":null,"abstract":"<p><p>PurposeThe 2023 American College of Physicians (ACP) guidelines for colorectal cancer (CRC) screening are at odds with the United States Preventive Task Force (USPSTF) guidelines, with the former recommending screening starting at age 50 y and the latter at age 45 y. This article \"stress tests\" CRC colonoscopy screening strategies to investigate their robustness to uncertainties stemming from the natural history of disease and sensitivity of colonoscopy.MethodsThis study uses the CRC-SPIN microsimulation model to project the life-years gained (LYG) under several colonoscopy CRC screening strategies. The model was extended to include birth cohort effects on adenoma risk. We estimated natural history parameters under 2 different assumptions about the youngest age of adenoma initiation. For each, we generated 500 parameter sets to reflect uncertainty in the natural history parameters. We simulated 26 colonoscopy screening strategies and examined 4 different colonoscopy sensitivity assumptions, encompassing the range of sensitivities consistent with prior tandem colonoscopy studies. Across this set of scenarios, we identify efficient screening strategies and report posterior credible intervals for benefits of screening (LYG), burden (number of colonoscopies), and incremental burden-effectiveness ratios.ResultsProjected absolute screening benefits varied widely based on assumptions, but strategies starting at age 45 y were consistently in the efficiency frontier. Strategies in which screening starts at age 50 y with 10-y intervals were never efficient, saving fewer life-years than starting screening at age 45 y and performing colonoscopies every 15 y while requiring more colonoscopies per person.ConclusionsDecennial colonoscopy screening initiation at age 45 y remained a robust recommendation. Colonoscopy screening with a 10-y interval starting at age 50 y did not result in an efficient use of colonoscopies in any of the scenarios evaluated.HighlightsColorectal cancer colonoscopy screening strategies initiated at age 45 y were projected to yield more life-years gained while requiring the least number of colonoscopies across different model assumptions about disease natural history and colonoscopy sensitivity.Colonoscopy screening starting at age 50 y with a 10-y interval consistently underperformed strategies that started at age 45 y.</p>","PeriodicalId":49839,"journal":{"name":"Medical Decision Making","volume":" ","pages":"557-568"},"PeriodicalIF":3.1,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12167147/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144025061","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
People Living with Chronic Pain Experience a High Prevalence of Decision Regret in Canada: A Pan-Canadian Online Survey. 患有慢性疼痛的人在加拿大的决策后悔率很高:一项泛加拿大在线调查。
IF 3.1 3区 医学 Q2 HEALTH CARE SCIENCES & SERVICES Pub Date : 2025-05-01 Epub Date: 2025-03-22 DOI: 10.1177/0272989X251326069
Florian Naye, Yannick Tousignant-Laflamme, Maxime Sasseville, Chloé Cachinho, Thomas Gérard, Karine Toupin-April, Olivia Dubois, Jean-Sébastien Paquette, Annie LeBlanc, Isabelle Gaboury, Marie-Ève Poitras, Linda C Li, Alison M Hoens, Marie-Dominique Poirier, France Légaré, Simon Décary

Background(1) To estimate the prevalence of decision regret in chronic pain care, and (2) to identify factors associated with decision regret.DesignWe conducted a pan-Canadian cross-sectional online survey and reported the results following the Checklist for Reporting of Survey Studies guidelines. We recruited a sample of adults experiencing chronic noncancer pain. We used a stratified proportional random sampling based on the population and chronic pain prevalence of each province. We measured decision regret with the Decision Regret Scale (DRS) and decisional needs with the Ottawa Decision Support Framework. We performed descriptive analysis to estimate the prevalence and level of decision regret and multilevel multivariable regression analysis to identify factors associated with regret according to the STRengthening Analytical Thinking for Observational Studies recommendations.ResultsWe surveyed 1,649 people living with chronic pain, and 1,373 reported a most difficult decision from the 10 prespecified ones, enabling the collection of a DRS score. On a scale ranging from 0 to 100 where 1 reflects the presence of decision regret and 25 constitutes important decision regret, the mean DRS score in our sample was 28.8 (s = 19.6). Eighty-four percent of respondents experienced some decision regret and 50% at an important level. We identified 15 factors associated with decision regret, including 4 personal and 9 decision-making characteristics, and 2 consequences of the chosen option. Respondents with low education level and higher decisional conflict experienced more decision regret when the decision was deemed difficult.ConclusionsThis pan-Canadian survey highlighted a high prevalence and level of decision regret associated with difficult decisions for pain care. Decision making in pain care could be enhanced by addressing factors that contribute to decision regret.HighlightsWe conducted an online pan-Canadian survey and collected responses from a wide diversity of people living with chronic pain.More than 84% of respondents experienced decision regret and approximately 50% at an important level.We identified 15 factors associated with decision regret, including 4 personal and 9 decision-making characteristics, and 2 consequences of the chosen option.Our pan-Canadian survey reveals an urgent need of a shared decision-making approach in chronic pain care that can be potentiated by targeting multiple factors associated with decision regret.

(1)评估慢性疼痛护理中决策后悔的患病率;(2)确定决策后悔的相关因素。DesignWe进行了一项泛加拿大的横断面在线调查,并按照调查研究报告指南的核对表报告了结果。我们招募了一组经历慢性非癌性疼痛的成年人作为样本。我们采用分层比例随机抽样的基础上,人口和慢性疼痛患病率的每个省。我们用决策后悔量表(DRS)测量决策后悔,用渥太华决策支持框架测量决策需要。我们采用描述性分析来估计决策后悔的患病率和水平,并采用多水平多变量回归分析来确定与后悔相关的因素。结果我们调查了1,649名慢性疼痛患者,其中1,373人报告了10个预先指定的最困难的决定,从而收集了DRS评分。在从0到100的范围内,1代表决策后悔的存在,25代表重要决策后悔,我们样本中的平均DRS得分为28.8 (s = 19.6)。84%的受访者经历过一些决策后悔,50%的受访者经历过重要的决策后悔。我们确定了与决策后悔相关的15个因素,包括4个个人特征和9个决策特征,以及所选选项的2个后果。受教育程度低、决策冲突程度高的被调查者在被认为决策困难时的决策后悔程度更高。结论:这项泛加拿大调查强调了与疼痛护理困难决定相关的决策后悔的高患病率和高水平。通过解决导致决策后悔的因素,可以提高疼痛护理中的决策能力。我们进行了一项泛加拿大的在线调查,收集了来自各种慢性疼痛患者的反馈。超过84%的受访者经历过决策后悔,大约50%的受访者在重要层面上感到后悔。我们确定了与决策后悔相关的15个因素,包括4个个人特征和9个决策特征,以及所选选项的2个后果。我们的泛加拿大调查显示,在慢性疼痛护理中迫切需要一个共同的决策方法,可以通过针对与决策后悔相关的多种因素来增强。
{"title":"People Living with Chronic Pain Experience a High Prevalence of Decision Regret in Canada: A Pan-Canadian Online Survey.","authors":"Florian Naye, Yannick Tousignant-Laflamme, Maxime Sasseville, Chloé Cachinho, Thomas Gérard, Karine Toupin-April, Olivia Dubois, Jean-Sébastien Paquette, Annie LeBlanc, Isabelle Gaboury, Marie-Ève Poitras, Linda C Li, Alison M Hoens, Marie-Dominique Poirier, France Légaré, Simon Décary","doi":"10.1177/0272989X251326069","DOIUrl":"10.1177/0272989X251326069","url":null,"abstract":"<p><p>Background(1) To estimate the prevalence of decision regret in chronic pain care, and (2) to identify factors associated with decision regret.DesignWe conducted a pan-Canadian cross-sectional online survey and reported the results following the Checklist for Reporting of Survey Studies guidelines. We recruited a sample of adults experiencing chronic noncancer pain. We used a stratified proportional random sampling based on the population and chronic pain prevalence of each province. We measured decision regret with the Decision Regret Scale (DRS) and decisional needs with the Ottawa Decision Support Framework. We performed descriptive analysis to estimate the prevalence and level of decision regret and multilevel multivariable regression analysis to identify factors associated with regret according to the STRengthening Analytical Thinking for Observational Studies recommendations.ResultsWe surveyed 1,649 people living with chronic pain, and 1,373 reported a most difficult decision from the 10 prespecified ones, enabling the collection of a DRS score. On a scale ranging from 0 to 100 where 1 reflects the presence of decision regret and 25 constitutes important decision regret, the mean DRS score in our sample was 28.8 (<i>s</i> = 19.6). Eighty-four percent of respondents experienced some decision regret and 50% at an important level. We identified 15 factors associated with decision regret, including 4 personal and 9 decision-making characteristics, and 2 consequences of the chosen option. Respondents with low education level and higher decisional conflict experienced more decision regret when the decision was deemed difficult.ConclusionsThis pan-Canadian survey highlighted a high prevalence and level of decision regret associated with difficult decisions for pain care. Decision making in pain care could be enhanced by addressing factors that contribute to decision regret.HighlightsWe conducted an online pan-Canadian survey and collected responses from a wide diversity of people living with chronic pain.More than 84% of respondents experienced decision regret and approximately 50% at an important level.We identified 15 factors associated with decision regret, including 4 personal and 9 decision-making characteristics, and 2 consequences of the chosen option.Our pan-Canadian survey reveals an urgent need of a shared decision-making approach in chronic pain care that can be potentiated by targeting multiple factors associated with decision regret.</p>","PeriodicalId":49839,"journal":{"name":"Medical Decision Making","volume":" ","pages":"462-479"},"PeriodicalIF":3.1,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11992647/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143677338","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Effect of a Surgeon Communication Strategy on Treatment Preference for Thyroid Cancer: A Randomized Trial. 外科医生沟通策略对甲状腺癌治疗偏好的影响:一项随机试验。
IF 3.1 3区 医学 Q2 HEALTH CARE SCIENCES & SERVICES Pub Date : 2025-05-01 Epub Date: 2025-03-27 DOI: 10.1177/0272989X251325837
Catherine B Jensen, Brandy Sinco, Megan C Saucke, Kyle J Bushaw, Alexis G Antunez, Corrine I Voils, Susan C Pitt

BackgroundCancer diagnosis causes emotional distress, which can influence patients' treatment choice. This study aimed to investigate the effect of increased emotionally supportive surgeon communication in a virtual setting on treatment preference for thyroid cancer.DesignThis randomized trial (NCT05132478), conducted from November 2021 to February 2023, enrolled adults with ≤4-cm thyroid nodules not requiring surgery. Participants were randomized 1:1 to watch a virtual clinic visit depicting a patient-surgeon treatment discussion for low-risk thyroid cancer. Control and intervention videos were identical except for added emotionally supportive communication in the intervention. The primary outcome was treatment preference for total thyroidectomy or lobectomy. Secondary outcomes were perceived physician empathy, physician trust, decisional confidence, and disease-specific knowledge. An intention-to-treat analysis was performed using conditional regression to account for stratification by sex. Qualitative content analysis evaluated participants' open-ended responses about treatment choice and surgeon communication.ResultsOf 208 eligible patients, 118 (56.7%) participated. Participants were 85.6% female and 88.1% White. Overall, 89.0% (n = 105) of participants preferred lobectomy, which was similar between the intervention and control groups (90.0% v. 87.9%, respectively, P = 0.72). Compared with control, participants who viewed the consultation with enhanced communication perceived higher levels of physician empathy (34.5 ± 5.8 v. 25.9 ± 9.1, P < 0.001) and reported increased trust in the physician (12.0 ± 2.6 v. 10.4 ± 3.1, P < 0.001). The groups were similar in decisional confidence (7.6 ± 2.1 v. 7.7 ± 1.9, P = 0.74) and disease-specific knowledge. Prominent qualitative themes among participants choosing thyroid lobectomy included desire to avoid daily thyroid hormone (n = 53) and concerns about surgical complications (n = 25).ConclusionsIn this randomized controlled study, a significant proportion of participants preferred thyroid lobectomy if diagnosed with low-risk thyroid cancer. Participants perceived increased empathy when provided even in the virtual setting, which was associated with increased trust in the physician.HighlightsIn this single-site, randomized controlled trial, enhanced emotionally supportive surgeon communication had no effect on hypothetical treatment preference for low-risk thyroid cancer.Participants who experienced enhanced emotionally supportive surgeon communication perceived higher physician empathy and reported greater trust in the physician.The incorporation of empathetic communication during surgical consultation for low-risk thyroid cancer promotes patient trust and perception of empathy.

癌症诊断会导致情绪困扰,从而影响患者的治疗选择。本研究旨在探讨在虚拟环境中增加情感支持的外科医生交流对甲状腺癌治疗偏好的影响。该随机试验(NCT05132478)于2021年11月至2023年2月进行,纳入不需要手术治疗的≤4厘米甲状腺结节的成年人。参与者按1:1的比例随机观看一场虚拟的诊所访问,该访问描述了低风险甲状腺癌的患者与外科医生的治疗讨论。除了在干预中增加了情感支持交流外,控制视频和干预视频是相同的。主要结局是选择全甲状腺切除术还是肺叶切除术。次要结果是感知到的医生共情、医生信任、决策信心和疾病特异性知识。使用条件回归进行意向治疗分析,以解释性别分层。定性内容分析评估了参与者关于治疗选择和外科医生沟通的开放式回答。结果208例符合条件的患者中,118例(56.7%)参与了研究。参与者中85.6%为女性,88.1%为白人。总体而言,89.0% (n = 105)的参与者倾向于肺叶切除术,干预组与对照组相似(90.0% vs 87.9%, P = 0.72)。与对照组相比,看了加强沟通咨询的参与者对医生的同理心(34.5±5.8 vs . 25.9±9.1,P P P = 0.74)和疾病特异性知识的感知水平更高。在选择甲状腺小叶切除术的参与者中,突出的定性主题包括希望避免每天使用甲状腺激素(n = 53)和对手术并发症的担忧(n = 25)。结论:在这项随机对照研究中,如果诊断为低风险甲状腺癌,很大比例的参与者倾向于甲状腺小叶切除术。即使是在虚拟环境中,参与者也能感受到更多的同理心,这与对医生的信任增加有关。在这项单点随机对照试验中,增强的外科医生情感支持沟通对低风险甲状腺癌的假设治疗偏好没有影响。经历了情感支持的外科医生交流的参与者感知到更高的医生同理心,并报告了对医生更大的信任。在低风险甲状腺癌的外科会诊中纳入共情沟通可促进患者的信任和共情感知。
{"title":"The Effect of a Surgeon Communication Strategy on Treatment Preference for Thyroid Cancer: A Randomized Trial.","authors":"Catherine B Jensen, Brandy Sinco, Megan C Saucke, Kyle J Bushaw, Alexis G Antunez, Corrine I Voils, Susan C Pitt","doi":"10.1177/0272989X251325837","DOIUrl":"10.1177/0272989X251325837","url":null,"abstract":"<p><p>BackgroundCancer diagnosis causes emotional distress, which can influence patients' treatment choice. This study aimed to investigate the effect of increased emotionally supportive surgeon communication in a virtual setting on treatment preference for thyroid cancer.DesignThis randomized trial (NCT05132478), conducted from November 2021 to February 2023, enrolled adults with ≤4-cm thyroid nodules not requiring surgery. Participants were randomized 1:1 to watch a virtual clinic visit depicting a patient-surgeon treatment discussion for low-risk thyroid cancer. Control and intervention videos were identical except for added emotionally supportive communication in the intervention. The primary outcome was treatment preference for total thyroidectomy or lobectomy. Secondary outcomes were perceived physician empathy, physician trust, decisional confidence, and disease-specific knowledge. An intention-to-treat analysis was performed using conditional regression to account for stratification by sex. Qualitative content analysis evaluated participants' open-ended responses about treatment choice and surgeon communication.ResultsOf 208 eligible patients, 118 (56.7%) participated. Participants were 85.6% female and 88.1% White. Overall, 89.0% (<i>n</i> = 105) of participants preferred lobectomy, which was similar between the intervention and control groups (90.0% v. 87.9%, respectively, <i>P</i> = 0.72). Compared with control, participants who viewed the consultation with enhanced communication perceived higher levels of physician empathy (34.5 ± 5.8 v. 25.9 ± 9.1, <i>P</i> < 0.001) and reported increased trust in the physician (12.0 ± 2.6 v. 10.4 ± 3.1, <i>P</i> < 0.001). The groups were similar in decisional confidence (7.6 ± 2.1 v. 7.7 ± 1.9, <i>P</i> = 0.74) and disease-specific knowledge. Prominent qualitative themes among participants choosing thyroid lobectomy included desire to avoid daily thyroid hormone (<i>n</i> = 53) and concerns about surgical complications (<i>n</i> = 25).ConclusionsIn this randomized controlled study, a significant proportion of participants preferred thyroid lobectomy if diagnosed with low-risk thyroid cancer. Participants perceived increased empathy when provided even in the virtual setting, which was associated with increased trust in the physician.HighlightsIn this single-site, randomized controlled trial, enhanced emotionally supportive surgeon communication had no effect on hypothetical treatment preference for low-risk thyroid cancer.Participants who experienced enhanced emotionally supportive surgeon communication perceived higher physician empathy and reported greater trust in the physician.The incorporation of empathetic communication during surgical consultation for low-risk thyroid cancer promotes patient trust and perception of empathy.</p>","PeriodicalId":49839,"journal":{"name":"Medical Decision Making","volume":" ","pages":"426-436"},"PeriodicalIF":3.1,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11999764/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143722287","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Nonparametric Approach for Estimating the Effective Sample Size in Gaussian Approximation of Expected Value of Sample Information. 样本信息期望值高斯逼近中有效样本量估计的非参数方法。
IF 3.1 3区 医学 Q2 HEALTH CARE SCIENCES & SERVICES Pub Date : 2025-05-01 Epub Date: 2025-03-20 DOI: 10.1177/0272989X251324936
Linke Li, Hawre Jalal, Anna Heath

The effective sample size (ESS) measures the informational value of a probability distribution in terms of an equivalent number of study participants. The ESS plays a crucial role in estimating the expected value of sample information (EVSI) through the Gaussian approximation approach. Despite the significance of ESS, except for a limited number of scenarios, existing ESS estimation methods within the Gaussian approximation framework are either computationally expensive or potentially inaccurate. To address these limitations, we propose a novel approach that estimates the ESS using the summary statistics of generated datasets and nonparametric regression methods. The simulation experiments suggest that the proposed method provides accurate ESS estimates at a low computational cost, making it an efficient and practical way to quantify the information contained in the probability distribution of a parameter. Overall, determining the ESS can help analysts understand the uncertainty levels in complex prior distributions in the probability analyses of decision models and perform efficient EVSI calculations.HighlightsEffective sample size (ESS) quantifies the informational value of probability distributions, essential for calculating the expected value of sample information (EVSI) using the Gaussian approximation approach. However, current ESS estimation methods are limited by high computational demands and potential inaccuracies.We propose a novel ESS estimation method that uses summary statistics and nonparametric regression models to efficiently and accurately estimate ESS.The effectiveness and accuracy of our method are validated through simulations, demonstrating significant improvements in computational efficiency and estimation accuracy.

有效样本量(ESS)衡量的信息价值的概率分布的研究参与者的数量相等。在利用高斯近似方法估计样本信息期望值(EVSI)的过程中,ESS起着至关重要的作用。尽管ESS具有重要意义,但除了有限数量的场景外,现有的高斯近似框架内的ESS估计方法要么计算成本高,要么可能不准确。为了解决这些限制,我们提出了一种使用生成数据集的汇总统计和非参数回归方法来估计ESS的新方法。仿真实验表明,该方法以较低的计算成本提供了准确的ESS估计,是一种有效而实用的量化参数概率分布信息的方法。总体而言,确定ESS可以帮助分析师理解决策模型概率分析中复杂先验分布的不确定性水平,并执行有效的EVSI计算。有效样本大小(ESS)量化了概率分布的信息值,对于使用高斯近似方法计算样本信息的期望值(EVSI)至关重要。然而,目前的ESS估计方法受到高计算需求和潜在不准确性的限制。本文提出了一种利用汇总统计和非参数回归模型对ESS进行有效、准确估计的方法。通过仿真验证了该方法的有效性和准确性,证明了计算效率和估计精度的显著提高。
{"title":"A Nonparametric Approach for Estimating the Effective Sample Size in Gaussian Approximation of Expected Value of Sample Information.","authors":"Linke Li, Hawre Jalal, Anna Heath","doi":"10.1177/0272989X251324936","DOIUrl":"10.1177/0272989X251324936","url":null,"abstract":"<p><p>The effective sample size (ESS) measures the informational value of a probability distribution in terms of an equivalent number of study participants. The ESS plays a crucial role in estimating the expected value of sample information (EVSI) through the Gaussian approximation approach. Despite the significance of ESS, except for a limited number of scenarios, existing ESS estimation methods within the Gaussian approximation framework are either computationally expensive or potentially inaccurate. To address these limitations, we propose a novel approach that estimates the ESS using the summary statistics of generated datasets and nonparametric regression methods. The simulation experiments suggest that the proposed method provides accurate ESS estimates at a low computational cost, making it an efficient and practical way to quantify the information contained in the probability distribution of a parameter. Overall, determining the ESS can help analysts understand the uncertainty levels in complex prior distributions in the probability analyses of decision models and perform efficient EVSI calculations.HighlightsEffective sample size (ESS) quantifies the informational value of probability distributions, essential for calculating the expected value of sample information (EVSI) using the Gaussian approximation approach. However, current ESS estimation methods are limited by high computational demands and potential inaccuracies.We propose a novel ESS estimation method that uses summary statistics and nonparametric regression models to efficiently and accurately estimate ESS.The effectiveness and accuracy of our method are validated through simulations, demonstrating significant improvements in computational efficiency and estimation accuracy.</p>","PeriodicalId":49839,"journal":{"name":"Medical Decision Making","volume":" ","pages":"370-375"},"PeriodicalIF":3.1,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11992650/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143664966","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Do Treatment Choices by Artificial Intelligence Correspond to Reality? Retrospective Comparative Research with Necrotizing Enterocolitis as a Use Case. 人工智能的治疗选择是否符合现实?以坏死性小肠结肠炎为例的回顾性比较研究。
IF 3.1 3区 医学 Q2 HEALTH CARE SCIENCES & SERVICES Pub Date : 2025-05-01 Epub Date: 2025-03-12 DOI: 10.1177/0272989X251324530
Rosa Verhoeven, Stella Mulia, Elisabeth M W Kooi, Jan B F Hulscher

BackgroundIn cases of surgical necrotizing enterocolitis (NEC), the choice between laparotomy (LAP) or comfort care (CC) presents a complex, ethical dilemma. A behavioral artificial intelligence technology (BAIT) decision aid was trained on expert knowledge, providing an output as "x percentage of experts advise laparotomy for this patient." This retrospective study aims to compare this output to clinical practice.DesignVariables required for the decision aid were collected of preterm patients with NEC for whom the decision of LAP or CC had been made. These data were used in 2 BAIT model versions: one center specific, built on the input of experts from the same center as the patients, and a nationwide version, incorporating the input of additional experts. The Mann-Whitney U test compared the model output for the 2 groups (LAP/CC). In addition, model output was classified as advice for LAP or CC, after which the chi-square test assessed correspondence with observed decisions.ResultsForty patients were included in the study (20 LAP). Model output (x percentage of experts advising LAP) was higher in the LAP group than in the CC group (median 95.1% v. 46.1% in the center-specific version and 97.3% v. 67.5% in the nationwide version, both P < 0.001). With an accuracy of 85.0% by the center-specific and 80.0% by the nationwide version, both showed significant correspondence with observed decisions (P < 0.001).LimitationsWe are merely examining a proof of concept of the decision aid using a small number of participants from 1 center.ConclusionsThis retrospective study demonstrates that treatment choices by artificial intelligence align with clinical practice in at least 80% of cases.ImplicationsFollowing prospective validation and ongoing refinements, the decision aid may offer valuable support to practitioners in future NEC cases.HighlightsThis study assesses the output of behavioral artificial intelligence technology in deciding between laparotomy and comfort care in surgical necrotizing enterocolitis.The model output aligns with clinical practice in at least 80% of patient cases.Following prospective validation, the decision aid may offer valuable support to physicians working at the neonatal intensive care unit.

在手术坏死性小肠结肠炎(NEC)的病例中,选择剖腹手术(LAP)还是舒适护理(CC)是一个复杂的伦理困境。行为人工智能技术(BAIT)决策辅助系统接受了专家知识的培训,输出结果为“x百分比的专家建议该患者进行剖腹手术”。这项回顾性研究的目的是将这一结果与临床实践进行比较。辅助决策所需的设计变量收集已做出LAP或CC决定的NEC早产儿患者。这些数据被用于2个版本的BAIT模型:一个是特定于中心的,建立在与患者相同中心的专家的输入基础上,另一个是全国版本,纳入了其他专家的输入。Mann-Whitney U检验比较两组的模型输出(LAP/CC)。此外,模型输出被分类为LAP或CC的建议,之后卡方检验评估与观察到的决策的对应关系。结果共纳入40例患者(LAP 20例)。LAP组的模型输出(专家建议LAP的x百分比)高于CC组(中位数95.1% vs .中心特定版本46.1%,97.3% vs .全国版本67.5%,均为P P
{"title":"Do Treatment Choices by Artificial Intelligence Correspond to Reality? Retrospective Comparative Research with Necrotizing Enterocolitis as a Use Case.","authors":"Rosa Verhoeven, Stella Mulia, Elisabeth M W Kooi, Jan B F Hulscher","doi":"10.1177/0272989X251324530","DOIUrl":"10.1177/0272989X251324530","url":null,"abstract":"<p><p>BackgroundIn cases of surgical necrotizing enterocolitis (NEC), the choice between laparotomy (LAP) or comfort care (CC) presents a complex, ethical dilemma. A behavioral artificial intelligence technology (BAIT) decision aid was trained on expert knowledge, providing an output as \"<i>x</i> percentage of experts advise laparotomy for this patient.\" This retrospective study aims to compare this output to clinical practice.DesignVariables required for the decision aid were collected of preterm patients with NEC for whom the decision of LAP or CC had been made. These data were used in 2 BAIT model versions: one center specific, built on the input of experts from the same center as the patients, and a nationwide version, incorporating the input of additional experts. The Mann-Whitney <i>U</i> test compared the model output for the 2 groups (LAP/CC). In addition, model output was classified as advice for LAP or CC, after which the chi-square test assessed correspondence with observed decisions.ResultsForty patients were included in the study (20 LAP). Model output (<i>x</i> percentage of experts advising LAP) was higher in the LAP group than in the CC group (median 95.1% v. 46.1% in the center-specific version and 97.3% v. 67.5% in the nationwide version, both <i>P</i> < 0.001). With an accuracy of 85.0% by the center-specific and 80.0% by the nationwide version, both showed significant correspondence with observed decisions (<i>P</i> < 0.001).LimitationsWe are merely examining a proof of concept of the decision aid using a small number of participants from 1 center.ConclusionsThis retrospective study demonstrates that treatment choices by artificial intelligence align with clinical practice in at least 80% of cases.ImplicationsFollowing prospective validation and ongoing refinements, the decision aid may offer valuable support to practitioners in future NEC cases.HighlightsThis study assesses the output of behavioral artificial intelligence technology in deciding between laparotomy and comfort care in surgical necrotizing enterocolitis.The model output aligns with clinical practice in at least 80% of patient cases.Following prospective validation, the decision aid may offer valuable support to physicians working at the neonatal intensive care unit.</p>","PeriodicalId":49839,"journal":{"name":"Medical Decision Making","volume":" ","pages":"449-461"},"PeriodicalIF":3.1,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11992639/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143606101","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Health State Utility Values: The Implications of Patient versus Community Ratings in Assessing the Value of Care. 健康状态效用值:评估护理价值时患者与社区评分的含义。
IF 3.1 3区 医学 Q2 HEALTH CARE SCIENCES & SERVICES Pub Date : 2025-05-01 Epub Date: 2025-03-22 DOI: 10.1177/0272989X251326600
Risha Gidwani, Katherine W Saylor, Louise B Russell

BackgroundHealth-state utility values (HSUVs) are key inputs into cost-utility analyses. There is debate over whether they are best derived from the community or patients, with concerns raised that community-derived preferences may devalue benefits to ill, elderly, or disabled individuals. This tutorial compares the effects of using patient-derived HSUVs versus community-derived HSUVs on incremental cost-effectiveness ratios (ICERs) and shows their implications for policy.DesignWe review published studies that compared HSUVs derived from patients and the community. We then present equations for the gains in quality-adjusted life-years (QALYs) that would be estimated for an intervention using patient versus community HSUVs and discuss the implications of those QALY gains. We present a numerical example as another way of showing how ICERs change when using patient versus community HSUVs.ResultsPatient HSUVs are generally higher than community HSUVs for severe health states. When an intervention reduces mortality, patient ratings yield more favorable ICERs than do community ratings. However, when the intervention reduces morbidity, patient ratings yield less favorable ICERs. For interventions that reduce both morbidity and mortality, the effect on ICERs of patient versus community HSUVs depends on the relative contribution of each to the resulting QALYs.ConclusionsThe use of patient HSUVs does not consistently favor treatments directed at those patients. Rather, the effect depends on whether the intervention reduces mortality, morbidity, or both. Since most interventions do both, using patient HSUVs has mixed implications for promoting investments for people with illness and disabilities. A nuanced discussion of these issues is necessary to ensure that policy matches the intent of the decision makers.HighlightsThe debate about whether health state utility values (HSUVs) are best derived from patients or the community rests in part on the presumption that using community values devalues interventions for disabled persons or those with chronic diseases.However, we show why the effect of using patient HSUVs depends on whether the intervention in question primarily reduces mortality or morbidity or has substantial effects on both.If the intervention reduces mortality, using patient HSUVs will make the intervention appear more cost-effective than using community HSUVs, but if it reduces morbidity, using patient HSUVs will make the intervention appear less cost-effective.If the intervention reduces both morbidity and mortality, a common situation, the effect of patient versus community HSUVs depends on the relative magnitudes of the gains in quality and length of life.

健康状态效用值(hsuv)是成本效用分析的关键输入。关于他们是来自社区还是来自患者的最佳选择存在争议,人们担心来自社区的偏好可能会降低对病人、老年人或残疾人的好处。本教程比较了使用患者衍生的hsuv和使用社区衍生的hsuv对增量成本效益比(ICERs)的影响,并展示了它们对政策的影响。我们回顾了已发表的比较患者和社区hsuv的研究。然后,我们提出了质量调整生命年(QALYs)收益的公式,该公式将用于使用患者与社区hsuv进行干预的估计,并讨论了这些质量调整生命年收益的含义。我们提供了一个数值示例,作为另一种方式来显示使用患者和社区hsuv时ICERs如何变化。结果严重健康状态患者hsuv总体高于社区hsuv。当干预措施降低死亡率时,患者评分比社区评分产生更有利的ICERs。然而,当干预降低发病率时,患者评分产生的icer较差。对于降低发病率和死亡率的干预措施,患者与社区hsuv对ICERs的影响取决于两者对最终质量年的相对贡献。结论患者hsuv的使用并不总是有利于针对这些患者的治疗。相反,效果取决于干预是否降低死亡率,发病率,或两者兼而有之。由于大多数干预措施兼而有之,使用病人专用suv对于促进对疾病和残疾人的投资具有复杂的影响。有必要对这些问题进行细致入微的讨论,以确保政策符合决策者的意图。关于健康状态效用值(hsuv)是最好从患者还是从社区获得的争论部分基于这样一种假设,即使用社区价值降低了对残疾人或慢性病患者的干预措施的价值。然而,我们展示了为什么使用患者hsuv的效果取决于所讨论的干预是否主要降低死亡率或发病率,或者对两者都有实质性影响。如果干预降低了死亡率,使用患者专用suv将使干预看起来比使用社区专用suv更具成本效益,但如果降低了发病率,使用患者专用suv将使干预看起来成本效益较低。如果干预降低了发病率和死亡率,这是一种常见的情况,那么患者与社区hsuv的效果取决于在质量和生命长度方面获得的相对程度。
{"title":"Health State Utility Values: The Implications of Patient versus Community Ratings in Assessing the Value of Care.","authors":"Risha Gidwani, Katherine W Saylor, Louise B Russell","doi":"10.1177/0272989X251326600","DOIUrl":"10.1177/0272989X251326600","url":null,"abstract":"<p><p>BackgroundHealth-state utility values (HSUVs) are key inputs into cost-utility analyses. There is debate over whether they are best derived from the community or patients, with concerns raised that community-derived preferences may devalue benefits to ill, elderly, or disabled individuals. This tutorial compares the effects of using patient-derived HSUVs versus community-derived HSUVs on incremental cost-effectiveness ratios (ICERs) and shows their implications for policy.DesignWe review published studies that compared HSUVs derived from patients and the community. We then present equations for the gains in quality-adjusted life-years (QALYs) that would be estimated for an intervention using patient versus community HSUVs and discuss the implications of those QALY gains. We present a numerical example as another way of showing how ICERs change when using patient versus community HSUVs.ResultsPatient HSUVs are generally higher than community HSUVs for severe health states. When an intervention reduces <i>mortality</i>, patient ratings yield more favorable ICERs than do community ratings. However, when the intervention reduces <i>morbidity</i>, patient ratings yield less favorable ICERs. For interventions that reduce both morbidity and mortality, the effect on ICERs of patient versus community HSUVs depends on the relative contribution of each to the resulting QALYs.ConclusionsThe use of patient HSUVs does not consistently favor treatments directed at those patients. Rather, the effect depends on whether the intervention reduces mortality, morbidity, or both. Since most interventions do both, using patient HSUVs has mixed implications for promoting investments for people with illness and disabilities. A nuanced discussion of these issues is necessary to ensure that policy matches the intent of the decision makers.HighlightsThe debate about whether health state utility values (HSUVs) are best derived from patients or the community rests in part on the presumption that using community values devalues interventions for disabled persons or those with chronic diseases.However, we show why the effect of using patient HSUVs depends on whether the intervention in question primarily reduces mortality or morbidity or has substantial effects on both.If the intervention reduces mortality, using patient HSUVs will make the intervention appear more cost-effective than using community HSUVs, but if it reduces morbidity, using patient HSUVs will make the intervention appear less cost-effective.If the intervention reduces both morbidity and mortality, a common situation, the effect of patient versus community HSUVs depends on the relative magnitudes of the gains in quality and length of life.</p>","PeriodicalId":49839,"journal":{"name":"Medical Decision Making","volume":" ","pages":"347-357"},"PeriodicalIF":3.1,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12007435/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143677335","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Immediate Death: Not So Bad If You Discount the Future but Still Worse than It Should Be. 立即死亡:如果你不考虑未来,那还不算太坏,但仍然比它应该的更糟。
IF 3.1 3区 医学 Q2 HEALTH CARE SCIENCES & SERVICES Pub Date : 2025-05-01 Epub Date: 2025-03-20 DOI: 10.1177/0272989X251325828
Eleanor M Pullenayegum, Marcel F Jonker, Henry Bailey, Bram Roudijk

ObjectivesDiscrete choice experiments (DCEs) as a valuation method require preferences to be anchored on the quality-adjusted life-year scale, usually through tasks involving choices between immediate death and various impaired health states or between health states with varying durations of life. We sought to determine which anchoring approach aligns best with the composite time tradeoff (cTTO) method, with a view to informing a valuation protocol that uses DCEs in place of the cTTO.MethodsA total of 970 respondents from Trinidad and Tobago completed a DCE with duration survey. Tasks involved choosing between 2 lives with identical durations, followed by a third option, representing either full health for a number of years or immediate death. Data were analyzed using mixed logit models, both with and without exponential discounting for time preferences.ResultsAssuming linear time preferences, the estimated utility of immediate death was -2.1 (95% credible interval [CrI] -3.2 to -1.2) versus -0.28 (95% CrI -0.47, -0.10) when allowing for nonlinear time preferences. Under linear time preferences, the predicted health-state values anchored on duration had range (-1.03, 1) versus (0.34, 1) when anchored on immediate death. The ranges under nonlinear time preferences were (-0.54, 1) versus (-0.22, 1). The estimated discount parameter was 23% (95% CrI 22% to 25%).ConclusionsThe nonzero discount parameter indicates that time preferences were nonlinear. Nonlinear time preferences anchored on duration provided the closest match to the benchmark EQ-VT cTTO values in Trinidad and Tobago, whose range was (-0.6, 1). Thus, DCE with duration can provide similar values to cTTO provided that nonlinear time preferences are accounted for and anchoring is based on duration.HighlightsTime preferences for health states in Trinidad and Tobago were nonlinear.In discrete choice tasks, we show that immediate death has a utility less than zero.DCE utilities under nonlinear time preferences with anchoring on duration agreed well with cTTO utilities.

目的离散选择实验(dce)作为一种评估方法,通常通过涉及立即死亡和各种健康受损状态或不同寿命持续时间的健康状态之间的选择的任务,将偏好锚定在质量调整的生命-年尺度上。我们试图确定哪种锚定方法最符合复合时间权衡(cTTO)方法,以期通知使用dce代替cTTO的估值协议。方法对970名来自特立尼达和多巴哥的调查对象进行了持续时间调查。任务包括在两种寿命相同的生命之间进行选择,然后是第三种选择,代表多年的完全健康或立即死亡。数据分析使用混合logit模型,有和没有指数贴现的时间偏好。假设线性时间偏好,即时死亡的估计效用为-2.1(95%可信区间[CrI] -3.2至-1.2),而当允许非线性时间偏好时,估计效用为-0.28(95%可信区间[CrI] -0.47, -0.10)。在线性时间偏好下,以持续时间为锚定的健康状态预测值的范围为(-1.03,1),而以立即死亡为锚定的健康状态预测值的范围为(0.34,1)。非线性时间偏好下的范围为(- 0.54,1)vs(- 0.22,1)。估计的折扣参数为23% (95% CrI为22%至25%)。结论非零折现参数表明时间偏好是非线性的。基于持续时间的非线性时间偏好提供了与特立尼达和多巴哥基准EQ-VT cTTO值最接近的匹配,其范围为(-0.6,1)。因此,如果考虑非线性时间偏好和基于持续时间的锚定,具有持续时间的DCE可以提供与cTTO相似的值。特立尼达和多巴哥对健康状况的时间偏好是非线性的。在离散选择任务中,我们证明立即死亡的效用小于零。基于时间锚定的非线性时间偏好下的DCE效用与cTTO效用基本一致。
{"title":"Immediate Death: Not So Bad If You Discount the Future but Still Worse than It Should Be.","authors":"Eleanor M Pullenayegum, Marcel F Jonker, Henry Bailey, Bram Roudijk","doi":"10.1177/0272989X251325828","DOIUrl":"10.1177/0272989X251325828","url":null,"abstract":"<p><p>ObjectivesDiscrete choice experiments (DCEs) as a valuation method require preferences to be anchored on the quality-adjusted life-year scale, usually through tasks involving choices between immediate death and various impaired health states or between health states with varying durations of life. We sought to determine which anchoring approach aligns best with the composite time tradeoff (cTTO) method, with a view to informing a valuation protocol that uses DCEs in place of the cTTO.MethodsA total of 970 respondents from Trinidad and Tobago completed a DCE with duration survey. Tasks involved choosing between 2 lives with identical durations, followed by a third option, representing either full health for a number of years or immediate death. Data were analyzed using mixed logit models, both with and without exponential discounting for time preferences.ResultsAssuming linear time preferences, the estimated utility of immediate death was -2.1 (95% credible interval [CrI] -3.2 to -1.2) versus -0.28 (95% CrI -0.47, -0.10) when allowing for nonlinear time preferences. Under linear time preferences, the predicted health-state values anchored on duration had range (-1.03, 1) versus (0.34, 1) when anchored on immediate death. The ranges under nonlinear time preferences were (-0.54, 1) versus (-0.22, 1). The estimated discount parameter was 23% (95% CrI 22% to 25%).ConclusionsThe nonzero discount parameter indicates that time preferences were nonlinear. Nonlinear time preferences anchored on duration provided the closest match to the benchmark EQ-VT cTTO values in Trinidad and Tobago, whose range was (-0.6, 1). Thus, DCE with duration can provide similar values to cTTO provided that nonlinear time preferences are accounted for and anchoring is based on duration.HighlightsTime preferences for health states in Trinidad and Tobago were nonlinear.In discrete choice tasks, we show that immediate death has a utility less than zero.DCE utilities under nonlinear time preferences with anchoring on duration agreed well with cTTO utilities.</p>","PeriodicalId":49839,"journal":{"name":"Medical Decision Making","volume":" ","pages":"376-384"},"PeriodicalIF":3.1,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11992645/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143665109","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Medical Decision Making
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1